Sinphar Pharmaceutical (Taiwan) Market Value
| 1734 Stock | TWD 30.60 0.40 1.29% |
| Symbol | Sinphar |
Sinphar Pharmaceutical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sinphar Pharmaceutical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sinphar Pharmaceutical.
| 01/09/2023 |
| 11/29/2024 |
If you would invest 0.00 in Sinphar Pharmaceutical on January 9, 2023 and sell it all today you would earn a total of 0.00 from holding Sinphar Pharmaceutical Co or generate 0.0% return on investment in Sinphar Pharmaceutical over 690 days. Sinphar Pharmaceutical is related to or competes with Taiwan Semiconductor, Hon Hai, MediaTek, Chunghwa Telecom, Formosa Petrochemical, Delta Electronics, and Cathay Financial. ,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care food... More
Sinphar Pharmaceutical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sinphar Pharmaceutical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sinphar Pharmaceutical Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 18.28 | |||
| Value At Risk | (2.31) | |||
| Potential Upside | 0.9836 |
Sinphar Pharmaceutical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sinphar Pharmaceutical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sinphar Pharmaceutical's standard deviation. In reality, there are many statistical measures that can use Sinphar Pharmaceutical historical prices to predict the future Sinphar Pharmaceutical's volatility.| Risk Adjusted Performance | (0.1) | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.58) | |||
| Treynor Ratio | (0.54) |
Sinphar Pharmaceutical Backtested Returns
Sinphar Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.22, which indicates the firm had a -0.22% return per unit of risk over the last 3 months. Sinphar Pharmaceutical Co exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sinphar Pharmaceutical's Variance of 3.89, coefficient of variation of (725.03), and Risk Adjusted Performance of (0.1) to confirm the risk estimate we provide. The entity has a beta of 0.52, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Sinphar Pharmaceutical's returns are expected to increase less than the market. However, during the bear market, the loss of holding Sinphar Pharmaceutical is expected to be smaller as well. At this point, Sinphar Pharmaceutical has a negative expected return of -0.16%. Please make sure to validate Sinphar Pharmaceutical's coefficient of variation, information ratio, total risk alpha, as well as the relationship between the standard deviation and jensen alpha , to decide if Sinphar Pharmaceutical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.24 |
Weak predictability
Sinphar Pharmaceutical Co has weak predictability. Overlapping area represents the amount of predictability between Sinphar Pharmaceutical time series from 9th of January 2023 to 20th of December 2023 and 20th of December 2023 to 29th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sinphar Pharmaceutical price movement. The serial correlation of 0.24 indicates that over 24.0% of current Sinphar Pharmaceutical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.24 | |
| Spearman Rank Test | -0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 6.25 |
Sinphar Pharmaceutical lagged returns against current returns
Autocorrelation, which is Sinphar Pharmaceutical stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sinphar Pharmaceutical's stock expected returns. We can calculate the autocorrelation of Sinphar Pharmaceutical returns to help us make a trade decision. For example, suppose you find that Sinphar Pharmaceutical has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sinphar Pharmaceutical regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sinphar Pharmaceutical stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sinphar Pharmaceutical stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sinphar Pharmaceutical stock over time.
Current vs Lagged Prices |
| Timeline |
Sinphar Pharmaceutical Lagged Returns
When evaluating Sinphar Pharmaceutical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sinphar Pharmaceutical stock have on its future price. Sinphar Pharmaceutical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sinphar Pharmaceutical autocorrelation shows the relationship between Sinphar Pharmaceutical stock current value and its past values and can show if there is a momentum factor associated with investing in Sinphar Pharmaceutical Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sinphar Stock Analysis
When running Sinphar Pharmaceutical's price analysis, check to measure Sinphar Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sinphar Pharmaceutical is operating at the current time. Most of Sinphar Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Sinphar Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sinphar Pharmaceutical's price. Additionally, you may evaluate how the addition of Sinphar Pharmaceutical to your portfolios can decrease your overall portfolio volatility.